1Edfeldt K, Swedenborg J, Hansson GK, et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation, 2002, 105:1158-1161.
2Walton KA, Hsieh X. Gharavi N. et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl sn glycero 3 phospho rylcholine mediated synthesis of interleukin-8. A role for Toll- like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem. 2003. 278:29661-29666.
3Li H, He Y, Zhang J, et al. Lipopolysaccharide regulates Toll- like receptor 4 expression in human aortic smooth muscle cells. Cell Biol Int, 2007, 31 : 831-835.
4Sukkar MB, Xie S. Khorasani NM. et al. ToLl like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol. 2006, 118:641-648.
5Vink A. Schoneveld AH. van der Meer JJ. et al. In vivo evi dence for a role of Toll like receptor 4 in the development of inritual lesions. Circulation. 2002. 106: 1985-1990.
6Spirig R, van Kooten C, Obregon C, et al. The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenmypic and functional maturation of human dendritic cells. J Immunol. 2008. 181: 878-890.
7Lim WS, Timmins JM. Seimon TA. et al. Signal transducer and activator of transcription 1 is critical for apoptosis in macro phages subjecled to endoplasmic reticulum stress in vitro and in advanced atherosclerotic lesions in vivo. Circulation. 2008. 117: 940-951.
8Michelsen KS, Wong MH. Shah PK. et al. Lack of Toll-like receptor 4 or mycloic differentiation factor 88 reduces athero sclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA, 2004. 101 : 10679-10684.
9Shinohara M, Hirata K. Yamashita T, et al. Localoverexpres sion of Toll-like receplors at the vessel wall induces atheroscle rotic lesion formation: synergism of TLR2 and TI,R4. Arterio scler Thromb Vasc Biol. 2007. 27:2384-2391.
10Harrington I.S. Belcher E, Moreno L, et al. Homeostatic role of Toll-like receptor 4 in the endothelium and heart. J Cardiovasc Pharmacol Ther. 2007, 12:322-326.
二级参考文献14
1Jian-Gao Fan~1 Liang-Hua Chen~2 Zheng-Jie Xu~1 Min-De Zeng~3 1 Department of Gastroenterology,Shanghai First People’s Hospital,Shanghai 200085,China2 Department of Cardiology,Shandong Provincial Hospital,Jinan 250021,China3 Shanghai Institute of Digestive Diseases,Shanghai 200080,China.Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver[J].World Journal of Gastroenterology,2001,7(5):710-712. 被引量：8
